Accelerate Diagnostics reported $75.85M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Accelerate Diagnostics AXDX:US USD 75.85M 17.12M
Becton, Dickinson and BDX:US USD 53.13B 195M
Bio Rad Laboratories BIO:US USD 12.06B 623.66M
Bruker BRKR:US USD 3.34B 47.9M
Danaher DHR:US USD 84.35B 3.32B
Exact Sciences EXAS:US USD 6.31B 130.59M
Hologic HOLX:US USD 9.29B 219.1M
Meridian Bioscience VIVO:US USD 463.1M 2.83M
Myriad Genetics MYGN:US USD 1.21B 1.8M
Nanostring Technologies NSTG:US USD 383.6M 29.78M
Pacific Biosciences Of California PACB:US USD 1.82B 57.19M
Perkinelmer PKI:US USD 13.82B 365.94M
Quidel QDEL:US USD 8.66B 166.9M
Thermo Fisher Scientific TMO:US USD 97.29B 6.75B